The House Concurrent Resolution, introduced by Representative Bayham, calls on the United States Congress to take necessary actions to ensure that the Food and Drug Administration (FDA) fulfills its responsibilities regarding the inspection and testing of imported seafood. The resolution highlights the significant volume of seafood imports into the U.S., which accounted for approximately 86% of consumption in 2022, and raises concerns about the safety of these products. A study conducted by Louisiana State University revealed alarming levels of harmful substances in imported shrimp, including banned drugs and sulfites, which pose serious health risks to consumers. The resolution emphasizes that the FDA's current inspection practices are inadequate compared to those of foreign counterparts, particularly in the European Union, where stricter standards are enforced.

The resolution urges Congress to compel the FDA to enhance its oversight of imported seafood to ensure consumer safety. It also calls for support of recommendations made by the Government Accountability Office (GAO) regarding the FDA's inspection practices, which have not met mandated targets since 2018. The Louisiana Legislature aims to address the discrepancies in seafood safety regulations and protect public health by advocating for increased scrutiny and testing of imported seafood products. A copy of the resolution will be sent to relevant congressional leaders and Louisiana's congressional delegation to promote action on this critical issue.